Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Role of Ghrelin in Cancer Cachexia

Next Previous
Trial Profile

The Role of Ghrelin in Cancer Cachexia

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anamorelin (Primary)
  • Indications Cachexia; Non-small cell lung cancer
  • Focus Pharmacodynamics

Most Recent Events

  • 09 Aug 2016 Status changed from active, no longer recruiting to discontinued due to poor recruitment.
  • 02 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov .
  • 29 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2016, as per ClinicalTrials.gov .

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top